Jeffrey Hawkins of Illumina is Elected to the Board of ACMG Foundation for Genetic and Genomic Medicine

News provided by

American College of Medical Genetics and Genomics

Apr 26, 2017, 15:38 ET

BETHESDA, Md., April 26, 2017 /PRNewswire-USNewswire/ -- Jeffrey A. Hawkins, Vice President and General Manager of Reproductive Genetic Health at Illumina, Inc., has been elected to the ACMG Foundation for Genetic and Genomic Medicine Board of Directors. The ACMG Foundation is a national nonprofit foundation dedicated to facilitating the integration of genetics and genomics into medical practice. The board members are active participants in serving as advocates for the Foundation and for advancing its policies and programs. Hawkins has been elected to a 6-year term starting immediately.

Hawkins joined Illumina in 2015 and leads the company's Reproductive Genetic Health business unit. Prior to joining Illumina, he served as Senior Vice President of Global Marketing and Program Management for GenMark Diagnostics from the pre-IPO phase in 2009 until his departure in 2015.

For the decade prior to GenMark, Hawkins served in various positions of increasing responsibility across R&D, sales, marketing and manufacturing in the clinical diagnostics field for Hologic, Third Wave Technologies and Abbott Laboratories. He holds a BA in Chemistry with honors from Concordia University and an MBA from Keller Graduate School of Management.

"We are excited to welcome Jeff Hawkins to the ACMG Foundation Board of Directors. His experience in the application of genomic technologies in the healthcare arena will be a great asset in guiding Foundation initiatives in genomic medicine," said Bruce R. Korf, MD, PhD, FACMG, president of the ACMG Foundation.

The complete list of the ACMG Foundation board of directors is at www.acmgfoundation.org.

About the ACMG Foundation for Genetic and Genomic Medicine

The ACMG Foundation for Genetic and Genomic Medicine, a 501(c)(3) nonprofit organization, is a community of supporters and contributors who understand the importance of medical genetics and genomics in healthcare. Established in 1992, the ACMG Foundation for Genetic and Genomic Medicine supports the American College of Medical Genetics and Genomics' mission to "translate genes into health" by raising funds to attract the next generation of medical geneticists and genetic counselors, to sponsor important research, to promote information about medical genetics, and much more.

To learn more about the important mission and projects of the ACMG Foundation for Genetic and Genomic Medicine and how you too can support this great cause, please visit www.acmgfoundation.org or contact us at [email protected] or 301-718-2014.

SOURCE American College of Medical Genetics and Genomics